Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy
Go back to Sarepta Therapeutics and Summit Enter Into Exclusive License and Collaboration Agreement for European Rights to Summit’s Utrophin Modulator Pipeline for the Treatment of Duchenne Muscular Dystrophy| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 14.24 -0.04 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.28 | 52 Week High | $19.75 | |||
| Open | $13.93 | 52 Week Low | $4.26 | |||
| Day High | $14.81 | P/E | N/A | |||
| Day Low | $13.93 | EPS | $0.00 | |||
| Volume | 4,522,127 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 17.28 -0.37 (2.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.65 | 52 Week High | $63.73 | |||
| Open | $17.33 | 52 Week Low | $8.00 | |||
| Day High | $17.80 | P/E | N/A | |||
| Day Low | $17.22 | EPS | $-5.69 | |||
| Volume | 1,478,701 | |||||
| AyreTrade, Inc. (AMEX: SUMM) | Delayed: 0.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.06 | 52 Week High | $0.24 | |||
| Open | $40.78 | 52 Week Low | $0.02 | |||
| Day High | $0.06 | P/E | N/A | |||
| Day Low | $0.06 | EPS | $0.00 | |||
| Volume | 7,226,927 | |||||
